Paper38175
National Cooperative Crohn's Disease Study: study design and conduct of the study.
Winship DH and 6 others. Gastroenterology, 1979. Cited by 137 papers, by iCite.
Cite this record
ConductScience Library. National Cooperative Crohn's Disease Study: study design and conduct of the study. Papers, record 38175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38175
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Crohn Disease | Major topic |
| Azathioprine | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Prednisone | |
| Random Allocation | |
| Recurrence | |
| Research Design | |
| Sulfasalazine | |
| United States |
Source PubMed
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42232212 | Impact of Paediatric-Onset Inflammatory Bowel Disease on Educational Paths and Careers. | Inflamm Intest Dis | 2026 | https://conductscience.org/library/papers/42232212 | PubMed |
| 40971924 | Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease. | Inflamm Bowel Dis | 2025 | https://conductscience.org/library/papers/40971924 | PubMed |
| 39055374 | HLA-DQA1*05 correlates with increased risk of anti-drug antibody development and reduced response to infliximab in Chinese patients with Crohn's disease. | Gastroenterol Rep (Oxf) | 2024 | https://conductscience.org/library/papers/39055374 | PubMed |
| 38667499 | Fecal Calprotectin in Patients with Crohn's Disease: A Study Based on the History of Bowel Resection and Location of Disease. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/38667499 | PubMed |
| 35664492 | Venlafaxine as an Adjuvant Therapy for Inflammatory Bowel Disease Patients With Anxious and Depressive Symptoms: A Randomized Controlled Trial. | Front Psychiatry | 2022 | https://conductscience.org/library/papers/35664492 | PubMed |
| 32994692 | Updated bone mineral density status in Saudi patients with inflammatory bowel disease. | World J Gastroenterol | 2020 | https://conductscience.org/library/papers/32994692 | PubMed |
| 32382271 | Work Productivity Loss in Inflammatory Bowel Disease Patients in Turkey. | Gastroenterol Res Pract | 2020 | https://conductscience.org/library/papers/32382271 | PubMed |
| 31636478 | Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/31636478 | PubMed |
| 31512092 | Altered sleep quality is associated with Crohn's disease activity: an actimetry study. | Sleep Breath | 2020 | https://conductscience.org/library/papers/31512092 | PubMed |
| 31102158 | Patient and general population values for luminal and perianal fistulising Crohn's disease health states. | Eur J Health Econ | 2019 | https://conductscience.org/library/papers/31102158 | PubMed |
| 30225788 | Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. | Qual Life Res | 2019 | https://conductscience.org/library/papers/30225788 | PubMed |
| 28670235 | Ophthalmologic manifestations in patients with inflammatory bowel disease. | Intest Res | 2017 | https://conductscience.org/library/papers/28670235 | PubMed |
| 28228435 | Crohn's disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab. | BMJ Case Rep | 2017 | https://conductscience.org/library/papers/28228435 | PubMed |
| 27783843 | Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27783843 | PubMed |
| 27472702 | Factors affecting poor nutritional status after small bowel resection in patients with Crohn disease. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27472702 | PubMed |
| 27149857 | Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers. | BMC Med Imaging | 2016 | https://conductscience.org/library/papers/27149857 | PubMed |
| 26523111 | Are faecal markers good indicators of mucosal healing in inflammatory bowel disease? | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26523111 | PubMed |
| 26039678 | Budesonide for induction of remission in Crohn's disease. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/26039678 | PubMed |
| 25772778 | Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability. | Dig Dis Sci | 2015 | https://conductscience.org/library/papers/25772778 | PubMed |
| 22644337 | Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype. | J Gastroenterol | 2012 | https://conductscience.org/library/papers/22644337 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38175
GET https://conductscience.org/api/papers/v1/38175/cited_by?page=2